Methylamine

Methylamine

SCHEMBL3915422

CN.c1ccc2c(c1)C2

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29881712 0.89
SCHEMBL22081972 0.89 CYP1A2 (0.62)
SCHEMBL109650 0.89 CYP1A2 (0.62)
SCHEMBL1525601 0.89
Hydroxyamine SCHEMBL344671 0.86
Hydrazine SCHEMBL7478669 0.86 CYP1A2 (0.53)
SCHEMBL9521460 0.86
Hydrazine SCHEMBL6573930 0.86 CYP1A2 (0.53)
SCHEMBL9620436 0.86
Water SCHEMBL2528680 0.85

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023114125-A1 DETECTION DEVICE AND METHODS OF USE THEREOF AMULET, INC. (US) 2023-06-22 WO disclosed
CN-107266419-B Certain amino-pyridazines, compositions thereof, and methods of use thereof 赛特凯恩蒂克公司 2021-05-11 CN disclosed
CN-112047926-A Certain amino-pyrimidines, compositions thereof and methods of use thereof 赛特凯恩蒂克公司 2020-12-08 CN disclosed
CN-105712974-B Certain amino-pyrimidines, compositions thereof and methods of use thereof 赛特凯恩蒂克公司 2020-07-31 CN disclosed
US-20090209552-A1 Organic Compounds NOVARTIS AG 2009-08-20 US disclosed
EP-2032555-A1 PYRROLE DERIVATIVES WITH CRTH2 RECEPTOR MODULATOR ACTIVITY Novartis AG (CH) 2009-03-11 EP disclosed
WO-2007144127-A1 PYRROLE DERIVATIVES WITH CRTH2 RECEPTOR MODULATOR ACTIVITY NOVARTIS AG (CH) 2007-12-21 WO disclosed